Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$643,491,951
-$7,167,557 QoQ
Shares Held
3,818,037
-22.7% QoQ
Ownership
3.76%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#7
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (45.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
3,818,037 | $643,491,951 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
546,002 | $295,840,259 | |
| 3 | ZTS |
Zoetis Inc.
|
1,070,929 | $76,956,955 | |
| 4 | VTRS |
Viatris Inc
|
4,694,966 | $74,556,056 | |
| 5 | PRGO |
PERRIGO Co plc
|
3,480,666 | $36,164,117 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
261,250 | $28,983,071 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
6,465,921 | $27,221,524 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,525,686 | $24,456,745 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $643,491,951 | 3,818,037 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $650,659,508 | 4,938,967 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $464,026,058 | 3,271,706 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $389,364,703 | 2,773,648 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $189,793,780 | 1,510,015 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $118,854,075 | 1,074,630 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $258,925,621 | 1,896,891 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $212,382,834 | 1,843,281 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $168,377,979 | 1,223,055 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $137,176,747 | 994,611 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $97,351,138 | 738,852 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $42,070,725 | 373,962 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $33,730,921 | 357,698 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $23,389,310 | 231,074 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,724,540 | 106,535 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,065,774 | 113,603 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,120,042 | 32,007 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,820,218 | 72,749 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,561,373 | 100,521 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,561,767 | 47,563 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,942,530 | 40,511 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,093,349 | 42,091 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,084,638 | 11,316 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,723,763 | 49,124 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,876,374 | 48,167 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $2,948,758 | 34,070 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||